In silico drug repositioning of FDA-approved drugs to predict new inhibitors for alpha-synuclein aggregation

Sedighe Sadat Jafaripour, Sajjad Gharaghani, Elmira Nazarshodeh, Shozeb Haider, Ali Akbar Saboury. In silico drug repositioning of FDA-approved drugs to predict new inhibitors for alpha-synuclein aggregation. Computers & Chemistry, 88:107308, 2020. [doi]

Abstract

Abstract is missing.